Literature DB >> 1512047

Cells and cytokines in mucosal immunity and inflammation.

K W Beagley1, C O Elson.   

Abstract

The mucosal immune system consists of a number of compartments that are populated with a different assortment of cells and serve different functions. The cytokines produced by the cells in each of these compartments are currently being defined. This is best understood in relation to B cells, whose proliferation and maturation is guided by a sequence of cytokines. PP are inductive sites that preferentially stimulate IgA production. At least in part, this preference seems to be due to the T cells located in PP, which have been shown to stimulate switching to IgA production by cognate interactions and production of TGF-beta. Postswitch B cells expressing surface IgA respond to IL-5, a cytokine produced by T cells in GALT. Terminal differentiation to IgA-producing plasma cells in the lamina propria may be driven by IL-6, which can be produced by a variety of cells in the lamina propria and by epithelial cells. T cells in the lamina propria have an assortment of surface markers consistent with both activation and memory and appear to produce a variety of cytokines in the local environment that presumably act in normal host defense. IEL consist mainly of CD8+ T cells. They have been shown to produce IFN-gamma and, very likely, other cytokines that presumably act in a paracrine fashion on local enterocytes. How these cells and cytokines are perturbed during intestinal inflammation is currently being defined. A certain assortment of cytokines are greatly increased in IBD. This assortment, including IL-1, IL-6, and IL-8, is elevated in a wide variety of chronic inflammatory states in other tissues as well. A critical requirement for cytokines to exert their effects is the expression of specific receptors on target cells. Virtually nothing is known about this aspect of mucosal immunity, but receptor expression on mucosal cells must be defined before we will be able to understand the complex interactions among lymphoid cells, the cytokines they produce, and the local stromal and epithelial cells.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1512047

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  20 in total

1.  Stimulatory and costimulatory effects of IL-18 directed to different small intestinal CD43 T cell subsets.

Authors:  Dina Montufar-Solis; Heuy-Ching Wang; John R Klein
Journal:  J Leukoc Biol       Date:  2007-08-16       Impact factor: 4.962

2.  Energy restriction and exercise differentially enhance components of systemic and mucosal immunity in mice.

Authors:  Connie J Rogers; David Berrigan; David A Zaharoff; Kenneth W Hance; Arti C Patel; Susan N Perkins; Jeffrey Schlom; John W Greiner; Stephen D Hursting
Journal:  J Nutr       Date:  2008-01       Impact factor: 4.798

3.  Cytokine gene transcription of human colonic intraepithelial lymphocytes costimulated with epithelial cells bearing HLA-DR and its inhibition by 5-aminosalicylic acid.

Authors:  D Chen; G Radford-Smith; M C Dipaolo; I McGowan; D P Jewell
Journal:  J Clin Immunol       Date:  1996-07       Impact factor: 8.317

4.  Enteric beta-defensin: molecular cloning and characterization of a gene with inducible intestinal epithelial cell expression associated with Cryptosporidium parvum infection.

Authors:  A P Tarver; D P Clark; G Diamond; J P Russell; H Erdjument-Bromage; P Tempst; K S Cohen; D E Jones; R W Sweeney; M Wines; S Hwang; C L Bevins
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

5.  Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses.

Authors:  D J Berg; N Davidson; R Kühn; W Müller; S Menon; G Holland; L Thompson-Snipes; M W Leach; D Rennick
Journal:  J Clin Invest       Date:  1996-08-15       Impact factor: 14.808

Review 6.  Assessing mucosal humoral immunity.

Authors:  S J Challacombe
Journal:  Clin Exp Immunol       Date:  1995-05       Impact factor: 4.330

7.  Increased expression of long pentraxin PTX3 in inflammatory bowel diseases.

Authors:  Shingo Kato; Mitsuko Ochiai; Tomoya Sakurada; Shino Ohno; Kyoko Miyamoto; Mina Sagara; Masataka Ito; Kyoko Takeuchi; Junko Imaki; Kazuro Itoh; Koji Yakabi
Journal:  Dig Dis Sci       Date:  2007-11-08       Impact factor: 3.199

8.  Hyaluronan-mediated leukocyte adhesion and dextran sulfate sodium-induced colitis are attenuated in the absence of signal transducer and activator of transcription 1.

Authors:  Sudip K Bandyopadhyay; Carol A de la Motte; Sean P Kessler; Vincent C Hascall; David R Hill; Scott A Strong
Journal:  Am J Pathol       Date:  2008-09-25       Impact factor: 4.307

9.  Serum IL-6: a candidate biomarker for intracranial pressure elevation following isolated traumatic brain injury.

Authors:  Georgene W Hergenroeder; Anthony N Moore; J Philip McCoy; Leigh Samsel; Norman H Ward; Guy L Clifton; Pramod K Dash
Journal:  J Neuroinflammation       Date:  2010-03-11       Impact factor: 8.322

10.  Ocular surface epithelium induces expression of human mucosal lymphocyte antigen (HML-1) on peripheral blood lymphocytes.

Authors:  J A P Gomes; H S Dua; L V Rizzo; M Nishi; A Joseph; L A Donoso
Journal:  Br J Ophthalmol       Date:  2004-02       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.